Kurt G. Briscoe devotes his practice to patent, trademark, and other intellectual property matters.

Kurt has over 25 years of experience in intellectual property law, including five years, from 1983 to 1988, as an examiner in the United States Patent and Trademark Office. Most of Kurt’s practice, including his experience as a patent examiner, has been in the field of pharmaceuticals and biotechnology.

Kurt regularly represents domestic and international companies in connection with the preparation and prosecution of patent and trademark applications. In addition, he regularly negotiates licensing and nondisclosure agreements for these clients. Kurt provides experienced worldwide IP portfolio management, including strategic, freedom-to-operate, invalidity, and infringement opinions. Kurt also performs due diligence for clients prior to their acquisition of patents and trademarks to reveal any patent validity or enforceability problems, or patent prosecution events that impact patent claim scope.

Kurt is also experienced in trade secret law. He assists clients in drafting and reviewing legal agreements related to unpatented products, inventions, processes, and other forms of proprietary information.

In addition to the pharmaceuticals and biotechnology industries, Kurt has extensive experience in the chemical, medical and dental device, and adhesive technology industries.



  • AIA Strategies.” Germany, May 6-12, 2012
  • Are Genes Patentable?,” Yorktown Bar Association, May 25, 2011
  • “Software and Business Method Patents: A Defensive & Offensive Strategy,” Minority Corporate Counsel Association (MCCA) 5th Annual CLE Expo, March 15-17, 2006

Contact This Attorney

  • This field is for validation purposes and should be left unchanged.